2m 2m 2m 2m 2m 2m 2m
ALIGOS THERAPT (ALGS)
NASDAQ
$5.58-$0.07 (-1.31%)
Price as of Jun 23, 2026 7:09 PM EDT- $30.7MMarket Cap
- -31.43%1-Year Change
- BiotechnologyIndustry
ALIGOS THERAPT (ALGS)
$5.58-$0.07 (-1.31%)
ALGS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.65 | ||
Change | -$0.04 (-0.70%) | ||
Open | $5.61 | ||
High | $5.94 | ||
Low | $5.48 | ||
Previous Close | $5.69 | ||
Volume | 61,457 | ||
30-Day Average Volume | 99,445 | ||
1-Week Change | 13.23% | ||
1-Month Change | -1.91% | ||
1-Year Change | -31.43% | ||
3-Year Change | -76.60% | ||
5-Year Change | -99.10% | ||
Fundamentals | |||
Shares Outstanding | 5.4M | ||
Total Assets | $64.6M | ||
Market Cap | $30.7M | ||
Enterprise Value | $678,988.00 | ||
Period: QTR TTM FY | |||
Revenue | $2.8M | ||
Net Income | -$23.0M | ||
Free Cash Flow | -$23.1M | ||
EBIT | -$22.7M | ||
EBITDA | -$22.4M | ||
Net Working Capital | $36.3M | ||
EPS | -$2.21 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | 0 | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/19/2024 | ||
Earnings & Revenue